A systematic review on the use of new anticoagulants in pregnancy

Obstetric Medicine

Volumn 6, Issue 2, 2013, Pages 64-71

  Tang, Ai Wei ^a   Greer, Ian ^b  

^a LIVERPOOL WOMEN'S NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Anticoagulants; Direct factor Xa inhibitors; Direct thrombin inhibitors; Pregnancy

Indexed keywords

EID: 84938870518     PISSN: 1753495X     EISSN: 17534968     Source Type: Journal    
DOI: 10.1177/1753495X12472642     Document Type: Review

References (43)

1. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl. 1):1-203
2. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl):e691S-e736S
3. The acute management of thrombosis and embolism during pregnancy and the puerperium. RCOG Greentop Guidelines No 37b. 2010 (http://www.rcog.org.uk/files/rcog-corp/GTG37b_230611.pdf)
4. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005;106:401-7
5. Alban S. Adverse effects of heparin. Handb Exp Pharmacol 2012;207:211-63
6. Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 2006;95:949-57
7. Anand SS, Yusuf S. Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA 1999;282:2058-67
8. Lindhoff-Last E, Kreutzenbeck HJ, Magnani HN. Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost 2005;93:63-9
9. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003;1:1504-14
10. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162:1833-40
11. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028-40
12. Mehta RS. Novel oral anticoagulants. Part II: direct thrombin inhibitors. Expert Rev Hematol 2010;3:351-61
13. Testa L, Andreotti F, Biondi Zoccai GG, Burzotta F, Bellocci F, Crea F. Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients. Int J Cardiol 2007;122:117-24
14. Mehta RS. Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors). Expert Rev Hematol 2010;3:227-41
15. Weitz JI, Eikelboom JW, Samama MM. New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl):e120S-e151S
16. Dempfle CE. Minor transplacental passage of fondaparinux in vivo. N Engl J Med 2004;350:1914-5
17. Jappe U, Juschka U, Kuner N, Hausen BM, Krohn K. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Contact Dermatitis 2004;51:67-72
18. Schapkaitz E, Jacobson BF. Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy. S Afr Med J 2007;97:1255-7
19. Maetzke J, Hinrichs R, Staib G, Scharffetter-Kochanek K. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004;59:237-8
20. Gogarten W. Fondaparinux and epidural anaesthesia. Int J Obstet Anesth 2009;18:288; author reply 290
21. Llau JV. Epidural labor analgesia in a patient receiving fondaparinux. Int J Obstet Anesth 2009;18:288-9; author reply 290
22. Aiono-Le Tagaloa L, Carvalho B. Epidural labor analgesia in a patient receiving fondaparinux. Int J Obstet Anesth 2009;18:94-5
23. Parody R, Oliver A, Souto JC, Fontcuberta J. Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003;88:ECR32
24. Wijesiriwardana A, Lees DA, Lush C. Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. Blood Coagul Fibrinolysis 2006;17:147-9
25. Mazzolai L, Hohlfeld P, Spertini F, Hayoz D, Schapira M, Duchosal MA. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 2006;108:1569-70
26. Harenberg J. Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy. Thromb Res 2007;119:385-8
27. Gerhardt A, Zotz RB, Stockschlaeder M, Scharf RE. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost 2007;97:496-7
28. Knol HM, Schultinge L, Erwich JJ, Meijer K. Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost 2010;8:1876-9
29. Hajj-Chahine J, Jayle C, Tomasi J, Corbi P. Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia. Interact Cardiovasc Thorac Surg 2010;11:679-81
30. Ciurzynski M, Jankowski K, Pietrzak B, et al. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit 2011;17:CS56-59
31. Hellgren M, Johansson S, Eriksson UG, Wahlander K. The oral direct thrombin inhibitor, ximelagatran, an alternative for anticoagulant treatment during the puerperium and lactation. BJOG 2005;112:579-83
32. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):340S-80S
33. Huhle G, Geberth M, Hoffmann U, Heene DL, Harenberg J. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. Gynecol Obstet Invest 2000;49:67-9
34. Mehta R, Golichowski A. Treatment of heparin induced thrombocytopenia and thrombosis during the first trimester of pregnancy. J Thromb Haemost 2004;2:1665-6
35. Harenberg J, Jorg I, Bayerl C, Fiehn C. Treatment of a woman with lupus pernio, thrombosis and cutaneous intolerance to heparins using lepirudin during pregnancy. Lupus 2005;14:411-2
36. Aijaz A, Nelson J, Naseer N. Management of heparin allergy in pregnancy. Am J Hematol 2001;67:268-9
37. Hiwarkar P, Stasi R, Sutherland G, Shannon M. Deep vein and intracardiac thrombosis during the post-partum period in Behcet's disease. Int J Hematol 2010;91:679-86
38. Markwardt F, Fink G, Kaiser B, et al. Pharmacological survey of recombinant hirudin. Pharmazie 1988;43:202-7
39. Ekbatani A, Asaro LR, Malinow AM. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia. Int J Obstet Anesth 2010;19:82-7
40. Young SK, Al-Mondhiry HA, Vaida SJ, Ambrose A, Botti JJ. Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature. Pharmacotherapy 2008;28:1531-6
41. Taniguchi S, Fukuda I, Minakawa M, Watanabe K, Daitoku K, Suzuki Y. Emergency pulmonary embolectomy during the second trimester of pregnancy: report of a case. Surg Today 2008;38:59-61
42. Duhl AJ, Paidas MJ, Ural SH, et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007;197:457 e451-421
43. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. RCOG Greentop Guidelines. November 2009